In-hospital Stellate Ganglion Block for Arrhythmic Storm

Recruiting now

Conditions studied: Arrhythmic Storm, Electrical Storm, Ventricular Fibrillation, Ventricular Tachycardia

In brief

Arrhythmic storm is a real emergency and its treatment could be challenging. Antiarrhythmic drugs are few and often ineffective. Neuromodulation has been grown in evidences but no large multicentric studies are present in literature about safety and effectiveness of Percutaneous Stellate Ganglion Block (PSGB). Patients with an electrical storm refractory to at least one antiarrhythmic drug will receive PSGB and will be enrolled in the present study. The number of defibrillations before and after the treatment will be compared, complications will be annotated.

Key facts

Study ID
NCT05720936
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
People needed
500
Starts
2017-11-07
Expected to finish
2028-12-31
Last updated by the study team
2025-06-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.